The empirical use of echinocandins, which are a class of antifungal drugs that inhibit the synthesis of β-glucan in the fungal cell wall via noncompetitive inhibition of the enzyme 1,3-β glucan synthase [14,15,16], has been reported to significantly reduce overall mortality in candidemia [13]. Here, PPIB is linked to Candidemia.